Premium
Regression of Nevi After Candida Injection for the Treatment of Verruca Vulgaris
Author(s) -
Kollmann Emily,
Cleaver David,
Cleaver Lloyd,
Cleaver Jonathan
Publication year - 2016
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13055
Subject(s) - verruca vulgaris , medicine , immunotherapy , dermatology , vitiligo , immune system , immunology
The most common treatment methods for verruca vulgaris are destructive methods that are often painful and treat individual verruca. Thus immune modulators, including Candida immunotherapy, are used to treat persistent recalcitrant and multiple verrucas simultaneously. Very few side effects are reported with Candida immunotherapy; they include vitiligo and now halo nevi. Physicians need to be aware of and discuss side effects with patients undergoing Candida immunotherapy.